Parkside Financial Bank & Trust’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCR
SCM
QCM
Parkside Financial Bank & Trust's NVCR Position: Q2 2026 in Review
Parkside Financial Bank & Trust held its NovoCure (NVCR) position steady in Q2 2026 at 45 shares worth $682. The position accounts for ﹤0.01% of the portfolio, ranked #2536.
Parkside Financial Bank & Trust first reported a position in NVCR in Q3 2020 and has held it in 24 quarters since. The position peaked at $10K in Q2 2021. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.
- Parkside Financial Bank & Trust held 45 shares of NovoCure worth $682 as of Q2 2026.
- Parkside Financial Bank & Trust left its NovoCure share count unchanged in Q2 2026.
- NovoCure made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2536 holding.
- Parkside Financial Bank & Trust first reported a position in NovoCure in Q3 2020 and has held it in 24 quarters since.
- Parkside Financial Bank & Trust's NovoCure position peaked at $10K in Q2 2021.
- 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.